Literature DB >> 32875613

The quest for substrates and binding partners: A critical barrier for understanding the role of ADAMTS proteases in musculoskeletal development and disease.

Brandon Satz-Jacobowitz1, Dirk Hubmacher1.   

Abstract

Secreted ADAMTS metalloproteases are involved in the sculpting, remodeling, and erosion of connective tissues throughout the body, including in the musculoskeletal system. ADAMTS proteases contribute to musculoskeletal development, pathological tissue destruction, and are mutated in congenital musculoskeletal disorders. Examples include versican cleavage by ADAMTS9 which is required for interdigital web regression during limb development, ADAMTS5-mediated aggrecan degradation in osteoarthritis resulting in joint erosion, and mutations in ADAMTS10 or ADAMTS17 that cause Weill-Marchesani syndrome, a short stature syndrome with bone, joint, muscle, cardiac, and eye involvement. Since the function of ADAMTS proteases and proteases in general is primarily defined by the molecular consequences of proteolysis of their respective substrates, it is paramount to identify all physiological substrates for each individual ADAMTS protease. Here, we review the current knowledge of ADAMTS proteases and their involvement in musculoskeletal development and disease, focusing on some of their known physiological substrates and the consequences of substrate cleavage. We further emphasize the critical need for the identification and validation of novel ADAMTS substrates and binding partners by describing the principles of mass spectrometry-based approaches and by emphasizing strategies that need to be considered for validating the physiological relevance for ADAMTS-mediated proteolysis of novel putative substrates.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  ADAMTS-like proteins; N-terminomics; connective tissue; degradomics; extracellular matrix; protease

Mesh:

Substances:

Year:  2020        PMID: 32875613      PMCID: PMC7902295          DOI: 10.1002/dvdy.248

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  153 in total

1.  Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.

Authors:  J D Sandy; J Westling; R D Kenagy; M L Iruela-Arispe; C Verscharen; J C Rodriguez-Mazaneque; D R Zimmermann; J M Lemire; J W Fischer; T N Wight; A W Clowes
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

2.  Ehlers-Danlos arthrochalasia type (VIIA-B)--expanding the phenotype: from prenatal life through adulthood.

Authors:  M Klaassens; E Reinstein; Y Hilhorst-Hofstee; J J P Schrander; F Malfait; H Staal; L C ten Have; J Blaauw; H C J Roggeveen; D Krakow; A De Paepe; M A M van Steensel; G Pals; J M Graham; C T R M Schrander-Stumpel
Journal:  Clin Genet       Date:  2011-08-24       Impact factor: 4.438

3.  Time-Resolved Analysis of Matrix Metalloproteinase Substrates in Complex Samples.

Authors:  Pascal Schlage; Fabian E Egli; Ulrich Auf dem Keller
Journal:  Methods Mol Biol       Date:  2017

4.  ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo.

Authors:  Chris B Little; Laureane Mittaz; Daniele Belluoccio; Fraser M Rogerson; Ian K Campbell; Clare T Meeker; John F Bateman; Melanie A Pritchard; Amanda J Fosang
Journal:  Arthritis Rheum       Date:  2005-05

5.  Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains.

Authors:  Santiago Cal; Alvaro J Obaya; María Llamazares; Cecilia Garabaya; Víctor Quesada; Carlos López-Otín
Journal:  Gene       Date:  2002-01-23       Impact factor: 3.688

6.  Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.

Authors:  Ruo-Hua Song; Micky D Tortorella; Anne-Marie Malfait; James T Alston; Zhiyong Yang; Elizabeth C Arner; David W Griggs
Journal:  Arthritis Rheum       Date:  2007-02

7.  Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice.

Authors:  Sonya S Glasson; Roger Askew; Barbara Sheppard; Brenda A Carito; Tracey Blanchet; Hak-Ling Ma; Carl R Flannery; Kim Kanki; Eunice Wang; Diane Peluso; Zhiyong Yang; Manas K Majumdar; Elisabeth A Morris
Journal:  Arthritis Rheum       Date:  2004-08

8.  Adamts18 deletion results in distinct developmental defects and provides a model for congenital disorders of lens, lung, and female reproductive tract development.

Authors:  Dalya Ataca; Marian Caikovski; Alessandra Piersigilli; Alexandre Moulin; Charaf Benarafa; Sarah E Earp; Yakir Guri; Corinne Kostic; Yvan Arsenijevic; Raija Soininen; Suneel S Apte; Cathrin Brisken
Journal:  Biol Open       Date:  2016-11-15       Impact factor: 2.422

9.  Unusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease.

Authors:  Dirk Hubmacher; Michael Schneider; Steven J Berardinelli; Hideyuki Takeuchi; Belinda Willard; Dieter P Reinhardt; Robert S Haltiwanger; Suneel S Apte
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

10.  ADAMTS10-mediated tissue disruption in Weill-Marchesani syndrome.

Authors:  Ewa J Mularczyk; Mukti Singh; Alan R F Godwin; Francessco Galli; Neil Humphreys; Antony D Adamson; Aleksandr Mironov; Stuart A Cain; Gerhard Sengle; Ray P Boot-Handford; Giulio Cossu; Cay M Kielty; Clair Baldock
Journal:  Hum Mol Genet       Date:  2018-11-01       Impact factor: 6.150

View more
  4 in total

Review 1.  Metalloproteases in gonad formation and ovulation.

Authors:  Yong Zhu
Journal:  Gen Comp Endocrinol       Date:  2021-10-02       Impact factor: 2.822

2.  Alternative splicing of the metalloprotease ADAMTS17 spacer regulates secretion and modulates autoproteolytic activity.

Authors:  Zerina Balic; Saurav Misra; Belinda Willard; Dieter P Reinhardt; Suneel S Apte; Dirk Hubmacher
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.834

Review 3.  Regulation of ADAMTS Proteases.

Authors:  Keron W J Rose; Nandaraj Taye; Stylianos Z Karoulias; Dirk Hubmacher
Journal:  Front Mol Biosci       Date:  2021-06-29

Review 4.  ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment.

Authors:  Nathalie Théret; Fidaa Bouezzedine; Fida Azar; Mona Diab-Assaf; Vincent Legagneux
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.